Payment models of innovative medicinal products
Definitions of payment models to address market access and affordability of innovative medicinal products
|Discipline:||Health Technology Assessment||Startdatum:||In consultation|
|YearOfStudy:||Research master||Taal:||Dutch, English|
|Niveau:||WO Master||Locatie:||In consultation|
Innovative medicinal products often come with a considerable price tag. Examples of such products are oncologic agents, gene and cell-based therapies and many others often linked to precision medicine. These innovative therapies create opportunities for indications often thought to be incurable. However, their prices tags and evidentiary uncertainties cause concerns amongst health technology assessment bodies and payers. Recently, innovative payment models have emerged to address market access and affordability. Examples are outcomes-based payment, value-based pricing, performance-based contract. However, it is observed that with the rise of innovative payment models many new names and schemes are mentioned in literature, both peer-reviewed as well as grey literature. Definitions of innovative payment models seem to overlap or at least not be used in a consistent manner.
The aim of this research project is to conduct a comprehensive literature review to identify described payment models in literature and thereafter create a nomenclature structure. This will aid discussions of payment models, their designs, and applications in practice.
We seek a pro-active, curious, and independent student to conduct this research. A background in health economics and health technology assessment not necessary, an interest in the topic is. Experience with (biomedical) research, drug development, literature reviews and/or dissemination of large amounts of qualitative data is a plus.
Systematic Literature Search, Thematic Content Analysis, Qualitative Data Analysis